O. Kara, S. Acar, and T. . Elibol, “The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation”, Med Sci Discov, vol. 9, no. 6, pp. 324–333, Jun. 2022.